Retaane anecortave acetate depot 15 mg: Phase II/III

By WIR Staff | Aug 25, 2003 | 7:00 AM GMT

In a 24-month double-blind Phase II/III study in 128 patients, 73% of Retaane patients had stable or improved

Read the full 181 word article

How to gain access

Continue reading with a
two-week free trial.